Relevance of Molecular Monitoring of Transcript Level in RUNX1-RUNX1T1 AML

Molecular breakpoint level fluctuations monitoring during AML treatment and subsequent follow-up may have role in prognosis and improve treatment decisions.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Larisa Girshova, Ekaterina Ovsyannikova, Konstantin Bogdanov, Sergey Kuzin, Andrey Zaritskey Source Type: research